Position
Chief Scientific Officer
Company
Mosaic Therapeutics
BabrahamBiotechnologyHealth CareTherapeuticsDescription
Mosaic Therapeutics announced the appointment of Dr Stephen Shuttleworth as Chief Scientific Officer. He brings over 30 years of experience in pharmaceutical science and biotech leadership.
Quick answer
Mosaic Therapeutics Appoints Dr Stephen Shuttleworth as Chief Scientific Officer (November 17, 2025). Mosaic Therapeutics is based in Babraham, Cambridgeshire, United Kingdom.
- Who is the new Chief Scientific Officer at Mosaic Therapeutics?
- Mosaic Therapeutics named Stephen Shuttleworth Chief Scientific Officer, announced November 17, 2025.
- What did Mosaic Therapeutics announce on November 17, 2025?
- Mosaic Therapeutics announced the appointment of Dr Stephen Shuttleworth as Chief Scientific Officer. He brings over 30 years of experience in pharmaceutical science and biotech leadership.
- What does Mosaic Therapeutics do?
- Mosaic Therapeutics is an oncology therapeutics company that is building a category leader in Synergistic Precision Oncology.
- Where is Mosaic Therapeutics based?
- Mosaic Therapeutics is based in Babraham, Cambridgeshire, United Kingdom.
- Which similar companies made leadership changes around the same time?
- 4D Molecular Therapeutics (November 17, 2025), AdvanCell (November 17, 2025), OncoNano Medicine (November 17, 2025) and Cytokinetics (November 14, 2025) also announced leadership changes within 45 days of Mosaic Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- 4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer (November 17, 2025)
- AdvanCell Appoints Philina Lee as Chief Executive Officer (November 17, 2025)
- OncoNano Appoints Brent Sorrells as Chief Operating Officer (November 17, 2025)
- Cytokinetics Appoints Jeffrey J. Hessekiel as Executive Vice President, Chief Legal and Administrative Officer (November 14, 2025)
- Nasus Pharma Appoints Eyal Rubin as Chief Financial Officer (November 20, 2025)
- Qualigen Therapeutics, Inc. Appoints Koti Meka as Executive Director (November 20, 2025)
Who to call at Mosaic Therapeutics, and when
A new leader at Mosaic Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Mosaic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mosaic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mosaic Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mosaic Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Mosaic Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.